Recently opened studies

Below is a list of our lymphoma clinical trials opened within the last 3 months.

For all other open lymphoma clinical trials click here

 

 

Trial Name

 

Description

 

Click for further information (external page)

 

Date opened

 

C34004

 

Phase 2 Study of TAK-659 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

October 2017

 

 

JAVELIN DLBCL

 

A phase 1/3 trial testing a new drug avelumab.

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

October 2017

 

 

PQR309-005

 

A phase 2 trial testing a targeted drug, PQR309.

Suitable for patients with CNS (brain) lymphoma which has come back after previous treatment

 

 

 

November 2017

 

 

INCYTE (CITADEL-202)

 

A phase 2 trial testing a new drug, INCB050465

Suitable for patients with Diffuse Large B cell lymphoma which has come back after previous treatment.

 

 

 

October 2017

 

 

PCYC-1143

 

A phase 3 study of Ibrutinib in combination with Venetoclax in subjects with mantle cell lymphoma

Suitable for patients with mantle cell lymphoma which has come back after previous treatment.

 

 

 

November 2017

 

 

This list is updated fortnightly. Click here to see all of our open clinical trials.

;